Physician profile
Xiaoli Wang
NPI 1346684222
$2,499.41
in general payments reported to CMS, 2019-2025
24 companies · $98.81 in 2025
The $98.81 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $245 · 2021: $350 · 2022: $771 · 2023: $686 · 2024: $41.07 · 2025: $98.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $538.02 | 2019-2024 | Relistor |
| Boston Scientific Corporation | $405.41 | 2019-2023 | |
| Protega Pharmaceutials INC | $302.95 | 2022-2023 | Roxybond |
| Si-Bone, INC. | $161.94 | 2022-2023 | |
| Pfizer INC. | $136.08 | 2019-2021 | |
| Vertos Medical, INC. | $121.54 | 2023 | Mild Device Kit |
| Nevro Corp. | $121.53 | 2020-2021 | |
| Ibsa Pharma INC. | $112.99 | 2020-2023 | Tirosint, Licart |
| Medtronic, INC. | $101.58 | 2021-2023 | Intellis Adaptivestim |
| Spinal Simplicity, LLC | $98.81 | 2025 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $82.03 | 2020-2021 | |
| Abbvie INC. | $73.79 | 2021-2024 | |
| Scilex Pharmaceuticals INC. | $32.68 | 2021-2023 | Ztlido |
| Hikma Pharmaceuticals USA | $29.58 | 2022 | |
| Redhill Biopharma INC. | $24.56 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.52 | 2020 | |
| Grt US Holding, INC. | $20.54 | 2021 | |
| Medtronic USA, INC. | $18.60 | 2019 | |
| Novo Nordisk INC | $18.27 | 2023 | Wegovy |
| Stimwave Technologies Incorporated | $17.41 | 2022 | |
| Uswm, LLC | $17.09 | 2021 | |
| Amgen INC. | $16.60 | 2022 | |
| Allergan, INC. | $12.94 | 2020 | |
| Zyla Life Sciences, INC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaoli Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.